110 related articles for article (PubMed ID: 21450944)
21. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
Endo-Munoz L; Warby T; Harrich D; McMillan NA
Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
[TBL] [Abstract][Full Text] [Related]
23. The HIV-1 Tat Protein Enhances Splicing at the Major Splice Donor Site.
Mueller N; Pasternak AO; Klaver B; Cornelissen M; Berkhout B; Das AT
J Virol; 2018 Jul; 92(14):. PubMed ID: 29743356
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
25. Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors.
Sgarbanti M; Borsetti A; Moscufo N; Bellocchi MC; Ridolfi B; Nappi F; Marsili G; Marziali G; Coccia EM; Ensoli B; Battistini A
J Exp Med; 2002 May; 195(10):1359-70. PubMed ID: 12021315
[TBL] [Abstract][Full Text] [Related]
26. Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.
Choudhary SK; Archin NM; Margolis DM
J Infect Dis; 2008 Apr; 197(8):1162-70. PubMed ID: 18419522
[TBL] [Abstract][Full Text] [Related]
27. The receptor tyrosine kinase RON represses HIV-1 transcription by targeting RNA polymerase II processivity.
Klatt A; Zhang Z; Kalantari P; Hankey PA; Gilmour DS; Henderson AJ
J Immunol; 2008 Feb; 180(3):1670-7. PubMed ID: 18209063
[TBL] [Abstract][Full Text] [Related]
28. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain.
Parada CA; Roeder RG
Nature; 1996 Nov; 384(6607):375-8. PubMed ID: 8934526
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation.
Okamoto H; Cujec TP; Peterlin BM; Okamoto T
Virology; 2000 May; 270(2):337-44. PubMed ID: 10792993
[TBL] [Abstract][Full Text] [Related]
30. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
31. Targeting the DNA-PK complex: Its rationale use in cancer and HIV-1 infection.
Schwartz C; Rohr O; Wallet C
Biochem Pharmacol; 2019 Feb; 160():80-91. PubMed ID: 30529192
[TBL] [Abstract][Full Text] [Related]
32. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus.
Popik W; Pitha PM
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9573-7. PubMed ID: 1719535
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of the RAP74 subunit of TFIIF correlates with Tat-activated transcription of the HIV-1 long terminal repeat.
Zhou M; Kashanchi F; Jiang H; Ge H; Brady JN
Virology; 2000 Mar; 268(2):452-60. PubMed ID: 10704353
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Tat transactivation by the RNA polymerase II CTD-phosphatase FCP1.
Licciardo P; Napolitano G; Majello B; Lania L
AIDS; 2001 Feb; 15(3):301-7. PubMed ID: 11273209
[TBL] [Abstract][Full Text] [Related]
35. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
Xie B; Wainberg MA; Frankel AD
J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.
Vemula SV; Veerasamy R; Ragupathy V; Biswas S; Devadas K; Hewlett I
Viruses; 2015 Feb; 7(2):543-58. PubMed ID: 25664610
[TBL] [Abstract][Full Text] [Related]
37. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
[TBL] [Abstract][Full Text] [Related]
38. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5.
Ping YH; Chu CY; Cao H; Jacque JM; Stevenson M; Rana TM
Retrovirology; 2004 Dec; 1():46. PubMed ID: 15620346
[TBL] [Abstract][Full Text] [Related]
39. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus type 1 and 2 Tat proteins specifically interact with RNA polymerase II.
Mavankal G; Ignatius Ou SH; Oliver H; Sigman D; Gaynor RB
Proc Natl Acad Sci U S A; 1996 Mar; 93(5):2089-94. PubMed ID: 8700889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
